Growth Company Investor - Stock market recommendations on AIM and small cap companies

28 February 2015

Popular Topics within cash

Oxford BioMedica seeks partners 24/08/2010

Out-of-favour Oxford BioMedica is seeking partners to develop two gene therapies after interim losses up 177 per cent to £3.6 million.

Tags: Cash, Deals & contracts, Full list

Hardy shrinks first-half loss 19/08/2010

India-focused Hardy Oil and Gas is pursuing expansion after cutting interim losses 76 per cent to $1.35 million (£860,000).

Tags: Cash, Full list

Profits leap at Scientific Digital 19/07/2010

Scientific Digital Imaging remains acquisitive after lifting annual pre-tax profits more than fourfold to £258,000.

Tags: AIM, Boardroom moves, Cash, Growth Stocks

Zoo Digital wins US backing

New York-headquartered Multi Packaging Solutions (MPS) is to pay £859,456 for 9.1 per cent of AIM-quoted entertainment software and services provider Zoo Digital, with warrants to double that stake as part of a new strategic relationship between the two companies.

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Turnaround at Falkland Islands  23/06/2010

Falkland Island Holdings (FIH) has turned £627,000 annual losses into £5.7 million pre-tax profits and awaits imminent oil drilling results.

Tags: AIM, Cash, Dividend, Turnaround

Interim profits soar at Gooch 08/06/2010

Optical components and systems manufacturer Gooch & Housego saw pre-tax profits surge from £39,000 to £1.7 million in the half-year to March.

Tags: AIM, Cash, Growth Stocks

Young's cheers with profits push 03/06/2010

AIM-quoted pubs operator Young & Co's Brewery has buoyed investors' spirits with positive profits progression in a challenging year to March.

Tags: AIM, Cash, Growth Stocks

Profits slip at Hamworthy 02/06/2010

AIM-listed marine fluid-handling systems specialist Hamworthy has announced a dip in profits for the year to March.

Tags: AIM, Cash, Deals & contracts, Dividend

Renovo moots cosmetic deal 20/05/2010

Biopharmaceutical specialist Renovo is discussing potential cosmetic uses for its Juvidex wound-healing product after trimming interim losses.

Tags: Cash, Deals & contracts, Full list, Restructuring

Licence fees boost ImmuPharma 19/05/2010

Drug discoverer ImmuPharma has lifted annual pre-tax profits 85 per cent to £9.1 million after a £21 million licence payment.

Tags: AIM, Cash, Deals & contracts

Strategic Thought cuts deficit 12/05/2010

Risk management software developer Strategic Thought has reduced losses from £2.1 million to £767,000 on buoyant turnover. 

Tags: AIM, Cash, Deals & contracts, Growth Stocks

Losses double at Southern Cross 11/05/2010

Southern Cross Healthcare Group is pinning hopes on its 'New Horizons' recovery policy after nearly doubling interim losses to £22.9 million.

Tags: Boardroom moves, Cash, Full list

The AIM Invest forum

Showcasing a selection of the most promising mining, oil & gas companies or UK-based Plc’s listed on AIM. Register your interest today.

The World MoneyShow London: The ultimate event for investors and traders

Attend The World MoneyShow London, 7-8 November 2014 located at the Queen Elizabeth II Conference Centre for personalized advice to achieve any investing or trading objective!. Click here to book.

The VCT & EIS Investor Forum

This is the UK's must-attend event for VCT and EIS investors and the fund management community with panel debates, keynote speakers and live pitches in one place on one day. Click here to book.

What moves small-cap share prices?

A research report into the top-performing 100 companies below the FTSE 350 and on AIM. Click here to download.

Cash Shells 2014

This annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. You can purchase the directory for £350 (+VAT). More info


The Growth of Activist Investing in Europe, London

The Growth of Activist Investing in Europe taking place on June 2 in London will educate European company management on how to position themselves as this trend continues to grow. Register here.

Directors' Pay on AIM 2014

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1,044 AIM-quoted companies. The full report is available to order for £365 + VAT. Click here for more info

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Chair and Non-Executive Director Guidelines

Chris Spencer-Phillips, MD of First Flight Non-Executive Directors and ShareSoc - the UK Individual Shareholders Society have developed a set of guidelines covering the search, selection and remuneration of Chairs and Non-Executive Directors. Download the Non Executive Guidelines .

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular Topics